Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Senescence-Induced Chemoresistance in Triple Negative Breast Cancer and Evolution-Based Treatment Strategies
Anindita Chakrabarty, Shayantani Chakraborty, Ranjini Bhattacharya, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Tissue-resident macrophages are major tumor-associated macrophage resources, contributing to early TNBC development, recurrence, and metastases
Ryuichiro Hirano, Koki Okamoto, Miyu Shinke, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 28
Challenges for Triple Negative Breast Cancer Treatment: Defeating Heterogeneity and Cancer Stemness
Rinad Mahmoud, Paloma Ordóñez‐Morán, Cinzia Allegrucci
Cancers (2022) Vol. 14, Iss. 17, pp. 4280-4280
Open Access | Times Cited: 33
Targeting Senescence as a Therapeutic Opportunity for Triple-Negative Breast Cancer
Bruno de Paula, Rosalind Kieran, Samantha Shui Yuan Koh, et al.
Molecular Cancer Therapeutics (2023) Vol. 22, Iss. 5, pp. 583-598
Open Access | Times Cited: 16
Therapeutic Implications of the Drug Resistance Conferred by Extracellular Vesicles Derived from Triple-Negative Breast Cancer Cells
Yong Weon Yi
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3704-3704
Open Access | Times Cited: 15
Metronomic Chemotherapy: Anti-Tumor Pathways and Combination with Immune Checkpoint Inhibitors
Elena Muraro, Lorenzo Vinante, Elisabetta Fratta, et al.
Cancers (2023) Vol. 15, Iss. 9, pp. 2471-2471
Open Access | Times Cited: 15
Modeling of senescence-related chemoresistance in ovarian cancer using data analysis and patient-derived organoids
Xintong Cai, Yanhong Li, Jianfeng Zheng, et al.
Frontiers in Oncology (2024) Vol. 13
Open Access | Times Cited: 5
Fractionation and phytochemical composition of an ethanolic extract of Ziziphus nummularia leaves: antioxidant and anticancerous properties in human triple negative breast cancer cells
Rola Abdallah, Abdullah Shaito, Adnan Badran, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Pharmacological Modulation of Cellular Senescence: Implications for Breast Cancer Progression and Therapeutic Strategies
Jialing Xie, Xinxin Shu, Zilan-Xie, et al.
European Journal of Pharmacology (2025), pp. 177475-177475
Closed Access
Potentiating doxorubicin activity through BCL-2 inhibition in p53 wild-type and mutated triple-negative breast cancer
Anna Schreiber, Stephen G. Smoots, Marilyn M Jackson, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
The Hallmarks of Cancer as Eco-Evolutionary Processes
Ranjini Bhattacharya, Stanislav Avdieiev, Anuraag Bukkuri, et al.
Cancer Discovery (2025) Vol. 15, Iss. 4, pp. 685-701
Closed Access
The interplay of cellular senescence and reprogramming shapes the biological landscape of aging and cancer revealing novel therapeutic avenues
Fuping Ding, Ying Yu, Jiangqi Zhao, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
The Potential of Senescence as a Target for Developing Anticancer Therapy
Hyein Jo, Kyeonghee Shim, Dooil Jeoung
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3436-3436
Open Access | Times Cited: 10
Senescence Promotes the Recovery of Stemness among Cancer Cells via Reprograming
Di Wang, Lingbo Liu
Biomolecules (2024) Vol. 14, Iss. 3, pp. 288-288
Open Access | Times Cited: 3
INHBA regulates Hippo signaling to confer 5-FU chemoresistance mediated by cellular senescence in colon cancer cells
Zhan Zhang, Lili Chen, Qiao Yang, et al.
The International Journal of Biochemistry & Cell Biology (2024) Vol. 171, pp. 106570-106570
Closed Access | Times Cited: 3
Liposomal ATM siRNA delivery for enhancing triple-negative breast cancer immune checkpoint blockade therapy
Dianwen Yu, Hui Wang, Hui Liu, et al.
Journal of Biomaterials Applications (2023) Vol. 37, Iss. 10, pp. 1835-1846
Closed Access | Times Cited: 7
Metronomic chemotherapy in ovarian cancer
Vikas Garg, Lalit Kumar
Cancer Letters (2023) Vol. 579, pp. 216469-216469
Closed Access | Times Cited: 7
Persistent EGFR/K-RAS/SIAH pathway activation drives chemo-resistance and early tumor relapse in triple-negative breast cancer
Amy Tang, Richard Hoefer, Mary L. Guye, et al.
Cancer Drug Resistance (2022) Vol. 5, Iss. 3, pp. 691-702
Open Access | Times Cited: 12
In Vitro Investigation of Therapy-Induced Senescence and Senescence Escape in Breast Cancer Cells Using Novel Flow Cytometry-Based Methods
Fanni Tóth, Zahra Moftakhar, Federica Sotgia, et al.
Cells (2024) Vol. 13, Iss. 10, pp. 841-841
Open Access | Times Cited: 2
The dual role of cellular senescence in human tumor progression and therapy
Liang Ma, Jie Yu, Yidian Fu, et al.
MedComm (2024) Vol. 5, Iss. 9
Open Access | Times Cited: 2
INTERPLAY BETWEEN EPIGENETICS, SENESCENCE AND CELLULAR REDOX METABOLISM IN CANCER AND ITS THERAPEUTIC IMPLICATIONS
Geoffrey Balamurli, Angeline Qiu Xia Liew, Wee‐Wei Tee, et al.
Redox Biology (2024) Vol. 78, pp. 103441-103441
Open Access | Times Cited: 2
Biomimetic antimicrobial polymers—Design, characterization, antimicrobial, and novel applications
Haruko Takahashi, Iva Sovadinová, Kazuma Yasuhara, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2022) Vol. 15, Iss. 3
Open Access | Times Cited: 11
Proteomic characterisation of triple negative breast cancer cells following CDK4/6 inhibition
Melina Beykou, Mar Arias-García, Theodoros I. Roumeliotis, et al.
Scientific Data (2022) Vol. 9, Iss. 1
Open Access | Times Cited: 10
Unveiling innovative therapeutic strategies and future trajectories on stimuli-responsive drug delivery systems for targeted treatment of breast carcinoma
Israa Habeeb Naser, Muhaned Zaid, Eyhab Ali, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 6, pp. 3747-3770
Closed Access | Times Cited: 5
Cellular Senescence in Liver Cancer: How Dying Cells Become “Zombie” Enemies
Aurora Gazzillo, Camilla Volponi, Cristiana Soldani, et al.
Biomedicines (2023) Vol. 12, Iss. 1, pp. 26-26
Open Access | Times Cited: 5
Identifying potential ligand molecules EGFR mediated TNBC targeting the kinase domain-identification of customized drugs through in silico methods
A Vyshnavi, Krishnan Namboori
Research in Pharmaceutical Sciences (2023) Vol. 18, Iss. 2, pp. 121-137
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top